Mark Lampert is the founder of BVF Partners L.P., a San Francisco-based, private investment firm established in 1993. Mr. Lampert has engaged in ventures relating to the biotechnology industry since 1984. Most recently, Mr. Lampert was a Vice President at the investment banking firm Oppenheimer & Co. in New York , where he created novel biotechnology investment vehicles. Prior to joining Oppenheimer & Co., he founded Biotechnology Royalty Corp., which pooled biotechnology patent royalties owned by universities. From 1987 to 1990, Mr. Lampert headed business development for Cambridge NeuroScience, a public biotechnology company. From 1984 to 1986, Mr. Lampert served as Assistant to the President of the NutraSweet Company, a subsidiary of G.D. Searle & Co.. He started his career at the Boston Consulting Group. Mr. Lampert is a Director of Accumen, Inc., Biotica Technology, Ltd, CFD Therapeutics, and Mendel Biotechnology. He holds an AB Degree in chemistry from Harvard College and an MBA Degree from Harvard Business School.